Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Peripheral Artery Disease V: Postoperative Nursing Management
Chronic Pancreatitis II: Collaborative Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 18, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Loc Lam1, Vishal Bansal2, Thomas Chai3
1H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX.
COVID-19 infection may trigger recurrent chemotherapy-induced peripheral neuropathy (rCIPN). This case report highlights a potential link between SARS-CoV-2 and the return of neuropathy symptoms in cancer patients.
Area of Science:
Background: